Health News ArticlesExcerpts of key news articles on
Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.
For further exploration, delve into our comprehensive Health and Food Corruption Information Center.
Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.
Vermont Gov. Peter Shumlin ... signed into law a bill establishing a single-payer health care plan for the state, making Vermont the first state to do so. Shumlin lauded the legislation as an "economic and fiscal imperative" -- as well as a moral one. "This law recognizes an economic and fiscal imperative - that we must control the growth in health care costs that are putting families at economic risk and making it harder for small employers to do business," he said. "We have a moral imperative to fix this problem, with 47,000 Vermonters uninsured and another 150,000 underinsured and worried about how to afford keeping their families healthy." Vermont lawmakers passed the legislation in March by a 92-49 margin. At the time of its passage, Shumlin lauded the legislature for becoming "the first state in the country to make the first substantive step to deliver a health care system where health care will be a right and not a privilege." The legislation, when fully enacted, will guarantee every Vermont resident the right to enroll in a state-sponsored insurance plan, Green Mountain Care. The law is set to become operational in 2014.
Note: The huge medical and pharmaceutical industries in the U.S. have a vested interest in keeping health care private in order to maintain their massive profits. This may be why the important news above was hardly reported in the media. The rest of the industrialized world already knows that it is much cheaper for government to provide medical care than for the private sector. Yet the media, a major source of whose income comes from advertising by these industries, is quite biased against providing health care for all, unless it is done through a profitable private system.
Investigations have found that every single supermarket in Britain stocks meat and dairy from animals fed GM [Genetically Modified] soy. Leading brands including Cadbury, Unilever and Dairycrest, also use products from livestock fed GM. In fact the new technology is so widespread that it is likely at least one item of food you eat today will have come from an animal fed GM soy, whether it was the milk on your cereal or the bacon in your sandwich. But what effect is our growing reliance on soy having on the countries supplying Britain with this ‘invisible ingredient’? Paraguay ... in many ways [is] the perfect place to grow unsustainable soy. Ruled by despotic dictators for centuries, the country is famous for being a hot bed of drug smugglers [and] Nazi war criminals. Even now, with a new democratically government in place, corruption is rife and regulations to protect the people are lax to say the least. In the last year the amount of land planted with soy has grown to a record 2.6 million hectares, most of which is GM, leading to claims of deforestation, violent land disputes and the ‘poisoning’ of local communities. Already it is estimated that 90 per cent of the Atlantic Rainforest in Paraguay has been lost to make way for crops, taking with it thousands of unique plants species, hundreds of rare birds and endangered animals like the jaguar. Its not just animals that suffer. Groups of Guarani people claim they have been driven from their land by the soy farmers. ‘Campesinos’, the small farmers who have traditionally worked the land, also claim they have been displaced.
Note: Many are not aware that much of the food they eat, especially soy and corn, comes from geneticaly modified crops which have been shown to pose a major risk to health. For more, click here and here.
A new documentary [has been] produced and aired by Montana PBS, a non-profit publicly-supported broadcasting television service in the United States. Their programme, "Clearing the Smoke", investigates the science of marijuana, [exploring] how cannabis acts on the brain and in the body in medically beneficial ways to treat nausea, pain, epilepsy and possibly even cancer. This programme includes extensive interviews with patients, doctors, [and] researchers, and skeptics detail the promises and the limitations of medicinal cannabis. Marijuana use is illegal throughout many countries of the world for reasons that are not clear. This video is important because it mainly investigates the scientific basis underlying the medical benefits of marijuana use instead of focusing on the social, political and legal hysteria that have been attached to it. The paper mentioned in this video, Marijuana Reconsidered, was published in book form and can be purchased from Amazon. The author, Dr Grinspoon, is the world's leading authority on marijuana. In this book, Dr Grinspoon examines -- and debunks -- many of the common misconceptions about marijuana.
Note: For an intriguing two-minute video clip of this program showing that cannabis has cured some forms of cancer in mice, click here. For the full, astonishing PBS documentary, click here.
We all know that physical activity is beneficial in countless ways, but even so, Dr. Mark Tarnopolsky, a professor of pediatrics at McMaster University in Hamilton, Ontario, was startled to discover that exercise kept a strain of mice from becoming gray prematurely. In heartening new research published last week ... exercise reduced or eliminated almost every detrimental effect of aging in mice that had been genetically programmed to grow old at an accelerated pace. The mice that Dr. Tarnopolsky and his colleagues used lacked the primary mitochondrial repair mechanism, so they developed malfunctioning mitochondria early in their lives, as early as 3 months of age, the human equivalent of age 20. By the time they reached 8 months, or their early 60s in human terms, the animals were extremely frail and decrepit, with spindly muscles, shrunken brains, enlarged hearts, shriveled gonads and patchy, graying fur. All were dead before reaching a year of age. Except the mice that exercised. At 8 months, when their sedentary lab mates were bald, frail and dying, the running rats remained youthful. They had full pelts of dark fur, no salt-and-pepper shadings. They also had maintained almost all of their muscle mass and brain volume. At 1 year, none of the exercising mice had died. The researchers were surprised by the magnitude of the impact that exercise had on the animals’ aging process. They had not expected that it would affect every tissue and bodily system studied. Dr. Tarnopolsky’s students were impressed. “I think they all exercise now,” he said.
Note: For a treasure trove of other inspiring articles published in the major media, click here.
The Obama administration Thursday abandoned a proposal to restrict planting of genetically engineered alfalfa, the latest rule-making proposal shelved as part of the administration's review of "burdensome" regulation. Agriculture Secretary Tom Vilsack's decision not to regulate alfalfa genetically modified to survive applications of the Monsanto Co. herbicide Roundup is a victory for the big seed and agri-chemicals company and the American Farm Bureau Federation. The Obama administration said earlier this month it is reviewing all proposed government regulation to weed out proposals that are overly burdensome to businesses—part of a broader effort to repair relations with employers and industry. The administration has also shelved two proposed workplace-safety rules opposed by business. Alfalfa is raised as hay on about 20 million acres, making it the fourth-biggest U.S. crop by acreage. Only about 250,000 acres of alfalfa is raised organically, however. Some biotechnology officials have predicted that U.S. farmers will use genetically modified seeds to grow half of the nation's alfalfa. The vast majority of the nation's corn, soybeans and cotton are grown from genetically modified varieties.
Note: The US government once again sides with big business and endangers public health. For a powerful, well researched essay which shows how these genetically engineered crops have been proven to cause cancer and kill lab animals in many studies, click here. For more reliable information, click here and here.
More than 20% of patients who received an implantable cardioverter-defibrillator -- a high-tech device that produces electrical impulses to regulate heartbeats and prevent life-threatening arrhythmias -- in recent years were not good candidates to receive the device, a new study suggests. Researchers at Duke University looked at more than 111,000 patients who received ICD implants between 2006 and 2009. More than 25,000 of those patients did not meet evidence-based criteria for receiving the device, according to the study. The risk of dying in the hospital was significantly higher for patients who received the ICD but did not meet the criteria, and 1 out of 121 patients in this category experienced complications following the implant, the study found. Dr. Robert Michler, chairman of Cardiovascular and Thoracic Surgery at Montefiore-Einstein Heart Center, said the data should act as a "wake-up call" for physicians, surgeons and patients. "Doctors are well-intentioned, but not all doctors should be determining the use of what is a very sophisticated therapy," Michler says. He says that in this case electophysiologists should be making the final determination if the patient needs the device.
Note: For powerful information from a top MD on how the profit motive corrupts the medical industry and endangers our health, click here.
A Food and Drug Administration advisory committee said ... that the agency should look at updated data on mercury amalgam dental fillings that may indicate possible medical problems for patients. The panel -- after hearing two days of testimony from experts, members of the public and dental professionals -- recommended the FDA look at information updated since the agency ruled in 2009 that the mercury in dental fillings is not harmful. Public pressure prompted the panel's review, initiated less than 18 months after the agency's decision. Committee members listened to testimony by consumer and dental groups claiming the FDA used flawed science when it set the current guidelines for mercury safety levels. Some experts say mercury from these fillings penetrates into the body and damages human cells, especially in the brain, bones and kidneys. How much damage it is unknown, which is why the advisory committee is revisiting the issue. Some dentists did say they would avoid using amalgam fillings because of numerous public reports of mercury poisoning. "I always wondered why we were told by the (American Dental Association) to be careful when disposing of mercury. If it's so dangerous to the environment, why not my patients?" asked Dr. Stephen Markus, a dentist in the Philadelphia area.
Note: For key reports from reliable sources on health issues, click here.
Congress gave final approval ... to a child nutrition bill that expands the school lunch program and sets new standards to improve the quality of school meals, with more fruits and vegetables. School meal programs have a major impact on the nation’s health, and supporters of the bill said it could reduce the prevalence of obesity among children. The lunch program feeds more than 31 million children a day. The bill gives the secretary of agriculture authority to establish nutrition standards for foods sold in schools during the school day, including items in vending machines. The standards would require schools to serve more fruits and vegetables, whole grains and low-fat dairy products. And for the first time in more than three decades, the bill would increase federal reimbursement for school lunches beyond inflation — to help cover the cost of higher-quality meals. It would also allow more than 100,000 children on Medicaid to qualify automatically for free school meals.
Britain's health service makes it the only one of 11 leading industrialised nations where wealth does not determine access to care – providing the most widely accessible treatments at low cost among rich nations, a study has found. The survey, by US health thinktank the Commonwealth Fund, showed that while a third of American adults "went without recommended care, did not see a doctor when sick, or failed to fill prescriptions because of costs", this figure was only 6% in the UK and 5% in Holland. In all the countries surveyed except Britain, wealth was a significant factor in access to health, with patients earning less than the national average more likely to report trouble with medical bills and problems getting care because of cost. The survey, of 19,700 patients in 11 nations, found "substantial differences" among countries on access to care when sick, access after hours, and waiting times for specialised care. The NHS was also extremely cost-effective, with spending on health per person almost the lowest in the survey. A person in the UK paid $1,500 less than one in Switzerland and less than half the $7,538 paid by every American for healthcare. The report was particularly damning about the US, where it found patients "are far more likely than those in 10 other industrialised nations to go without healthcare because of costs".
Note: For highly informative reports from major media sources on health issues, click here.
About 48 of the more than 1,730 California doctors who received money from pharmaceutical companies over the past 21 months have been the subject of disciplinary action, a database compiled by the investigative news organization ProPublica found. While that represents less than 3 percent of the California doctors who take pharmaceutical money, the fact that drug companies are paying those doctors - some of whom have multiple disciplinary actions - for their expertise calls into question how closely these companies vet the physicians who serve as the spokespeople for their drugs. California doctors have received $28.6 million from top pharmaceutical companies since 2009, with at least three physicians collecting more than $200,000 and 36 others making more than $100,000 for promoting drug firm products. That cash flowing from drug companies to doctors has raised ethical concerns from some observers. "If they're getting as much money from pharmaceutical companies as they do for being a doctor, what are they really? Are they working for a pharmaceutical company, or are they being a doctor?" asked Lisa Bero, a pharmacy professor at UCSF who studies conflicts of interest in medicine and research.
Note: For a detailed analysis of corruption in the pharmaceutical industry by a highly-respected doctor, click here.
We are often the agents of our own pain. We cause our own deaths, conflicts, illnesses, every single day. We made cancer. Also, we invented war. Scientists have found almost no trace of cancer in the mummified remains of bodies from ancient civilizations. It simply did not exist. Cancer is [a] byproduct of heavily industrialized, high tech, toxic modern society. Same goes, in a way, for war and combat, our need to dominate and defeat. Plentiful are the cultures and peoples throughout time and geography that, even despite scarce natural resources, despite having all the supposed reasons to go to war, never once found a need to take up arms, or even understand the concept. War is learned behavior. Cancer is a modern invention, the dark underbelly of our madhouse race to progress. We create -- and even knowingly promote -- many of the sociocultural factors that spawn depression and internal demonization. But when it comes to love, sexuality, the infinite powers of the heart? It's just the opposite. The love, the sex, the chemistry of desire ... has its roots deep in our very being ... woven into our very DNA. You actually can't choose your particular wiring for love, but you can choose to be a warlike, antagonistic force of cancerous doom. We cannot design our innate sexual chemistry, but we sure as hell can choose whether to celebrate it with wine and song and fearless abandon, or poison it at its heart with ignorance, panic, a violent misreading of God.
WARNING: Holding a cellphone against your ear may be hazardous to your health. So may stuffing it in a pocket against your body. The legal departments of cellphone manufacturers slip a warning about holding the phone against your head or body into the fine print of the little slip that you toss aside when unpacking your phone. The warnings may be missed by an awful lot of customers. The United States has 292 million wireless numbers in use, approaching one for every adult and child. Devra Davis, an epidemiologist who has worked for the University of Pittsburgh ... has published a book about cellphone radiation, Disconnect: The Truth About Cell Phone Radiation, What the Industry Has Done to Hide It, and How to Protect Your Family. Her book ... surveys the scientific investigations and concludes that brain cancer is a concern. Children are more vulnerable to radiation than adults, Ms. Davis and other scientists point out. No field studies have been completed to date on cellphone radiation and children, she says. 28 percent of studies with cellphone industry funding showed some sort of effect, while 67 percent of studies without such funding did so. Ms. Davis recommends keeping a phone out of close proximity to the head or body, by using wired headsets or the phone’s speaker. Children should text rather than call, she said, and pregnant women should keep phones away from the abdomen. The best way to avoid exposure [is] by holding the cellphone away from the head or body.
Note: For highly informative reports from major media sources on health issues, click here.
In a rare move, the Justice Department on Tuesday announced that it had charged a former vice president and top lawyer for the British drug giant GlaxoSmithKline with making false statements and obstructing a federal investigation into illegal marketing of the antidepressant Wellbutrin for weight loss. "This is absolutely precedent-setting – this is really going to set people's hair on fire," said Douglas B. Farquhar, a Washington lawyer. "This is indicative of the F.D.A. and Justice strategy to go after the very top-ranking managing officials at regulated companies." The indictment accuses the Glaxo official, Lauren C. Stevens of Durham, N.C., of lying to the Food and Drug Administration in 2003, by writing letters, as associate general counsel, denying that doctors speaking at company events had promoted Wellbutrin for uses not approved by the agency. Ms. Stevens "made false statements and withheld documents she recognized as incriminating," including slides the F.D.A. had sought during its investigation, the indictment stated. The company was cooperating fully with a federal investigation into allegations of illegal sales and marketing of Wellbutrin. Last year, it set aside $400 million to resolve the case, which is still pending. Two weeks ago, in an unrelated case, GlaxoSmithKline agreed to pay $750 million to the government to settle civil and criminal complaints that it sold tainted or ineffective products from a large manufacturing facility in Puerto Rico.
Note: Even with fines in the hundreds of millions of dollars assessed to many of the large pharmaceuticals, why isn't more being done? See what one of the top doctors in the US revealed about corruption in health care at this link.
Few ecological disasters have been as confounding as the massive and devastating die-off of the world's honeybees. The phenomenon of Colony Collapse Disorder (CCD) -- in which disoriented honeybees die far from their hives -- has kept scientists, beekeepers, and regulators desperately seeking the cause. The long list of possible suspects has included pests, viruses, fungi, and also pesticides, particularly so-called neonicotinoids, a class of neurotoxins that kills insects by attacking their nervous systems. For years, their leading manufacturer, Bayer Crop Science, a subsidiary of the German pharmaceutical giant Bayer AG (BAYRY), has tangled with regulators and fended off lawsuits from angry beekeepers who allege that the pesticides have disoriented and ultimately killed their bees. A cheer must have gone up at Bayer on Thursday when a front-page New York Times article, under the headline "Scientists and Soldiers Solve a Bee Mystery," described how a newly released study pinpoints a different cause for the die-off: "a fungus tag-teaming with a virus." The Bayer pesticides, however, go unmentioned. What the Times article did not explore -- nor did the study disclose -- was the relationship between the study's lead author, Montana bee researcher Dr. Jerry Bromenshenk, and Bayer Crop Science. In recent years Bromenshenk has received a significant research grant from Bayer to study bee pollination.
Note: Read the full, revealing article to learn how money often corrupts science. For lots more from reliable sources on corporate corruption, click here.
GlaxoSmithKline, the British drug giant, has agreed to pay $750 million to settle criminal and civil complaints that the company for years knowingly sold contaminated baby ointment and an ineffective antidepressant – the latest in a growing number of whistle-blower lawsuits that drug makers have settled with multimillion-dollar fines. Altogether, GlaxoSmithKline sold 20 drugs with questionable safety that were made at a huge plant in Puerto Rico that for years was rife with contamination. Cheryl D. Eckard, the company's quality manager, asserted in her whistle-blower suit that she had warned Glaxo of the problems but the company fired her instead of addressing them. Among the drugs affected were Paxil, an antidepressant; Bactroban, an ointment; Avandia, a troubled diabetes drug; Coreg, a heart drug; and Tagamet, an acid reflux drug. Justice Department officials announced the settlement in a news conference Tuesday afternoon in Boston, saying a $150 million payment to settle criminal charges was the largest such payment ever by a manufacturer of adulterated drugs. The outcome also provides $600 million in civil penalties. The share to the whistle-blower will be $96 million, one of the highest such awards in a health care fraud case.
Note: For key reports from major media sources on corporate corruption and criminality, click here.
As you read this story, is your cell phone in your pocket or purse, on your desk beside you, or even in your hand? On a planet of 6.8 billion people, about 5 billion use cell phones. But could radiation from those phones be harmful to your health? In her new book, Disconnect: The Truth About Cell Phone Radiation, What the Industry Has Done to Hide It, and How to Protect Your Family, Devra Davis, an environmental health scientist formerly with the National Academy of Sciences, says the answer is a resounding yes. Over the years, scientists and public health officials have explored the effects of mobile phone radiation on human health. Time and again, they've said that while more research is needed to examine potential long-term effects, fears of cell phones are mostly unfounded. But Davis, who says she was once a skeptic herself, argues that compelling evidence to the contrary exists in research institutions around the world. Disconnect resurrects decades-old studies on the topic and probes new research to build a case for why cell phone radiation is now a "national emergency." "What I'm really concerned about here and why I wrote this book is because there's a lot of really compelling experimental evidence on the effect of electromagnetic fields on cells. We are already seeing a doubled risk of brain cancer in people who have used cell phones heavily for 10 years in the few studies that have been done," [said Davis].
Note: For key reports from major media sources on important health issues, click here.
Doctors and patients are being misled about the effectiveness of some drugs because negative trial results are not published, experts have warned. Writing in the British Medical Journal, they say that pharmaceutical companies should be forced to publish all data, not just positive findings. The German team give the example of the antidepressant reboxetine, saying publications have failed to show the drug in a true light. Reboxetine (Edronax), made by Pfizer, is used in many European countries, including the UK. But its rejection by US drug regulators raised doubts about its effectiveness, and led some to hunt for missing data. This is not the first time a large drug company has come under fire about its published drug trial data. Pharmaceutical giant GlaxoSmithKline (GSK) was criticised for failing to raise the alarm on the risk of suicidal behaviour associated with its antidepressant Seroxat. GSK has also been forced to defend itself over allegations about hiding negative data regarding another of its drugs, Avandia, which is used to treat diabetes. "Our findings underline the urgent need for mandatory publication of trial data," [the researchers] say in the BMJ. They warn that the lack of all information means policy makers are unable to make informed decisions. In the US, it is already a requirement that all data - both positive and negative - is published.
Note: For a powerful summary of government/corporate corruption in the pharmaceutical industry by a respected former editor of a major medical journal, click here.
Monsanto, the giant of agricultural biotechnology, has been buffeted by setbacks this year that have prompted analysts to question whether its winning streak of creating ever more expensive genetically engineered crops is coming to an end. The latest blow came last week, when early returns from this year’s harvest showed that Monsanto’s newest product, SmartStax corn, which contains eight inserted genes, was providing yields no higher than the company’s less expensive corn, which contains only three foreign genes. Monsanto has already been forced to sharply cut prices on SmartStax and on its newest soybean seeds, called Roundup Ready 2 Yield, as sales fell below projections. Sales of Monsanto’s Roundup, the widely used herbicide, has collapsed this year under an onslaught of low-priced generics made in China. Weeds are growing resistant to Roundup, dimming the future of the entire Roundup Ready crop franchise. And the Justice Department is investigating Monsanto for possible antitrust violations. Until now, Monsanto’s main challenge has come from opponents of genetically modified crops, who have slowed their adoption in Europe and some other regions. Now, however, the skeptics also include farmers and investors who were once in Monsanto’s camp.
Note: For those who are not aware of how Monsanto executives are quite consciously endangering your health, click here.
UC Davis just announced a seminar for the public on "men's health." That title notwithstanding, the program appears to be entirely about prostate cancer and in particular about the prostate specific antigen screening test. Many possible screening programs turn out not to do any good - and in fact some tests like PSA cause harm. That's why virtually all expert public health panels do not recommend the PSA test. A blood test that isn't accurate can fail to find disease that's present, leading to false reassurance. It can also report disease when it's not really there, leading to unnecessary use of other tests (like biopsy) that are not so benign. Perhaps most concerning, the PSA test frequently identifies something that qualifies as cancer under a microscope but acts nothing like cancer in real life. That is to say, the large majority of PSA-discovered "cancers" would never cause any problem whatsoever if they went undetected. Finding something through screening invariably leads to treating it. Most of the men so treated would have been just fine if they never knew about the cancer. But when they're treated ... the majority suffer really life-affecting effects, such as impotence and/or incontinence. That's why both of the two very large trials of PSA screening published in 2009 found no (or at most a tiny) benefit, but a great deal of harm.
Note: This article was written by Michael Wilkes, a professor of medicine at UC Davis, and Jerome Hoffman, a professor of emergency medicine at the University of Southern California. Both are researchers/consultants for the U.S. Centers for Disease Control and Prevention.
As the Food and Drug Administration considers whether to approve genetically modified salmon, one thing seems certain: Shoppers staring at fillets in the seafood department will find it tough to pick out the conventional fish from the one created with genes from another species. Despite a growing public demand for more information about how food is produced, that won't happen with the salmon because of idiosyncracies embedded in federal regulations. The FDA says it cannot require a label on the genetically modified food once it determines that the altered fish is not "materially" different from other salmon - something agency scientists have said is true. Perhaps more surprising, conventional food makers say the FDA has made it difficult for them to boast that their products do not contain genetically modified ingredients. The decision carries great weight because, while genetically modified agriculture has been permitted for years and engineered crops are widely used in processed foods, this would be the first modified animal allowed for human consumption in the United States. The AquAdvantage salmon has been given a gene from the ocean pout, an eel-like fish, and a growth hormone from a Chinook salmon. Consumer advocates say they worry about labeling for genetically engineered beef, pork and other fish, which are lining up behind the salmon for federal approval.
Note: For an excellent overview of the dangers of genetically modified foods, click here.
Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.